OB
Ollin BiosciencesClinical-stage biopharmaceutical company developing best-in-disease therapies for vision-threatening eye diseases, including a VEGF/Ang2 bispecific antibody in Phase 3 for DME and wet AMD.
2 Pulse stories
TM
Tenon MedicalTenon Medical develops the Catamaran, a minimally invasive titanium implant system for sacroiliac joint fusion to treat lower back pain.
1 Pulse story
Total Raised
$430M
Ollin BiosciencesTenon Medical
Last ValuationNot disclosed
Biotech
Sector
Biotech
2023
Founded
2012
Chicago, Illinois
HQ
Los Gatos, California
Private
Status
Public (TNON)
Ollin Biosciences investors
ARCH Venture PartnersTCGX (TCG Crossover)Andreessen HorowitzMubadala CapitalMonograph CapitalBlackstone Multi-Asset InvestingCommodore CapitalRA Capital Management
Tenon Medical investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Ollin Biosciences and Tenon Medical.